Akero Therapeutics, Inc (AKRO) insider trading
Every open-market stock purchase and sale by Akero Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $2.2M over the last 12 months (2 sales). No open-market buys.
- Last insider buy: G. Walmsley Graham (Insider), $2.2M, 18 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.2M (2 sales). Last close $54.65 on Dec 8, 2025.
Recent AKRO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $10M |
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $8.5M |
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $7.5M |
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $6.8M |
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $4.9M |
| Dec 9, 2025 | Scott A. Gangloff (CTO) | Sold (not open market) | $4M |
| Dec 9, 2025 | Patrick Lamy (Insider) | Sold (not open market) | $3.8M |
| Dec 9, 2025 | Catriona Yale (C-suite exec) | Sold (not open market) | $3.6M |
| Dec 9, 2025 | William Richard White (CFO) | Sold (not open market) | $3.6M |
| Dec 9, 2025 | Timothy Rolph (C-suite exec) | Sold (not open market) | $3.6M |
| Dec 9, 2025 | Jonathan Young (COO) | Sold (not open market) | $3.6M |
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $3.5M |
| Dec 9, 2025 | Jonathan Young (COO) | Sold (not open market) | $2.8M |
| Dec 9, 2025 | Catriona Yale (C-suite exec) | Sold (not open market) | $2.6M |
| Dec 9, 2025 | Timothy Rolph (C-suite exec) | Sold (not open market) | $2.4M |
| Dec 9, 2025 | William Richard White (CFO) | Sold (not open market) | $2.3M |
| Dec 9, 2025 | Scott A. Gangloff (CTO) | Sold (not open market) | $2.2M |
| Dec 9, 2025 | William Richard White (CFO) | Sold (not open market) | $2.1M |
| Dec 9, 2025 | Jonathan Young (COO) | Sold (not open market) | $2.1M |
| Dec 9, 2025 | Catriona Yale (C-suite exec) | Sold (not open market) | $2.1M |
| Dec 9, 2025 | William Richard White (CFO) | Sold (not open market) | $2.1M |
| Dec 9, 2025 | Jonathan Young (COO) | Sold (not open market) | $2.1M |
| Dec 9, 2025 | Catriona Yale (C-suite exec) | Sold (not open market) | $2.1M |
| Dec 9, 2025 | Andrew Cheng (CEO) | Sold (not open market) | $1.8M |
| Dec 9, 2025 | William Richard White (CFO) | Sold (not open market) | $1.7M |
Who's trading AKRO
- Andrew Cheng, CEO: sold $1.6M (1 sale), last Dec 9, 2025
- Scott A. Gangloff, CTO: other filings, last Dec 9, 2025
- G. Walmsley Graham, Insider: other filings, last Dec 9, 2025
- Seth Loring Harrison, Insider: other filings, last Dec 9, 2025
- Jane Henderson, Insider: other filings, last Dec 9, 2025
- Tomas J. Heyman, Insider: other filings, last Dec 9, 2025
- Mark T Iwicki, Insider: other filings, last Dec 9, 2025
- Chou Judy, Insider: other filings, last Dec 9, 2025
- Patrick Lamy, VP: other filings, last Dec 9, 2025
- Timothy Rolph, C-suite exec: sold $576K (2 sales), last Dec 9, 2025
- William Richard White, CFO: other filings, last Dec 9, 2025
- Yuan Xu, Insider: other filings, last Dec 9, 2025
- Catriona Yale, C-suite exec: other filings, last Dec 9, 2025
- Jonathan Young, COO: other filings, last Dec 9, 2025
Get free alerts when an insider at Akero Therapeutics, Inc files a new trade →